Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 185

1.

Strategies for early discharge of the hospitalized patient with community-acquired pneumonia.

Siegel RE.

Clin Chest Med. 1999 Sep;20(3):599-605. Review.

PMID:
10516907
2.
3.

Full-course oral levofloxacin for treatment of hospitalized patients with community-acquired pneumonia.

Erard V, Lamy O, Bochud PY, Bille J, Cometta A, Calandra T.

Eur J Clin Microbiol Infect Dis. 2004 Feb;23(2):82-8. Epub 2004 Jan 15.

PMID:
14727149
4.

Early switch and early discharge strategies in patients with community-acquired pneumonia: a meta-analysis.

Rhew DC, Tu GS, Ofman J, Henning JM, Richards MS, Weingarten SR.

Arch Intern Med. 2001 Mar 12;161(5):722-7.

PMID:
11231705
5.

In-hospital observation after antibiotic switch in pneumonia: a national evaluation.

Nathan RV, Rhew DC, Murray C, Bratzler DW, Houck PM, Weingarten SR.

Am J Med. 2006 Jun;119(6):512.e1-7.

PMID:
16750965
6.

Evaluation of an algorithm for switching from IV to PO therapy in clinical practice in patients with community-acquired pneumonia.

van der Eerden MM, de Graaff CS, Vlaspolder F, Bronsveld W, Jansen HM, Boersma WG.

Clin Ther. 2004 Feb;26(2):294-303.

PMID:
15038952
7.

Early transition to oral antibiotic therapy for community-acquired pneumonia: duration of therapy, clinical outcomes, and cost analysis.

Omidvari K, de Boisblanc BP, Karam G, Nelson S, Haponik E, Summer W.

Respir Med. 1998 Aug;92(8):1032-9.

8.

Achieving a safe and early discharge for patients with community-acquired pneumonia.

Rhew DC, Weingarten SR.

Med Clin North Am. 2001 Nov;85(6):1427-40. Review.

PMID:
11686189
9.

Switch therapy in community-acquired pneumonia.

Ramirez JA.

Diagn Microbiol Infect Dis. 1995 May-Jun;22(1-2):219-23.

PMID:
7587043
11.

Outpatient care compared with hospitalization for community-acquired pneumonia: a randomized trial in low-risk patients.

Carratalà J, Fernández-Sabé N, Ortega L, Castellsagué X, Rosón B, Dorca J, Fernández-Agüera A, Verdaguer R, Martínez J, Manresa F, Gudiol F.

Ann Intern Med. 2005 Feb 1;142(3):165-72.

PMID:
15684204
12.

Effect of a 3-step critical pathway to reduce duration of intravenous antibiotic therapy and length of stay in community-acquired pneumonia: a randomized controlled trial.

Carratalà J, Garcia-Vidal C, Ortega L, Fernández-Sabé N, Clemente M, Albero G, López M, Castellsagué X, Dorca J, Verdaguer R, Martínez-Montauti J, Manresa F, Gudiol F.

Arch Intern Med. 2012 Jun 25;172(12):922-8. doi: 10.1001/archinternmed.2012.1690.

PMID:
22732747
13.
14.

The antibiotic treatment of community-acquired, atypical, and nosocomial pneumonias.

Cunha BA.

Med Clin North Am. 1995 May;79(3):581-97. Review.

PMID:
7752730
15.

Comparative efficacies and tolerabilities of intravenous azithromycin plus ceftriaxone and intravenous levofloxacin with step-down oral therapy for hospitalized patients with moderate to severe community-acquired pneumonia.

Zervos M, Mandell LA, Vrooman PS, Andrews CP, McIvor A, Abdulla RH, de Caprariis PJ, Knirsch CA, Amsden GW, Niederman MS, Lode H.

Treat Respir Med. 2004;3(5):329-36.

PMID:
15606222
16.

The hospital discharge decision for patients with community-acquired pneumonia. Results from the Pneumonia Patient Outcomes Research Team cohort study.

Fine MJ, Medsger AR, Stone RA, Marrie TJ, Coley CM, Singer DE, Akkad H, Hough LJ, Lang W, Ricci EM, Polenik DM, Kapoor WN.

Arch Intern Med. 1997 Jan 13;157(1):47-56.

PMID:
8996040
17.

How short can courses be in lower respiratory tract infections?

Siegel R.

J Int Med Res. 2000;28 Suppl 1:37A-47A. Review.

PMID:
11092228
18.

Early switch to oral treatment in patients with moderate to severe community-acquired pneumonia: a meta-analysis.

Athanassa Z, Makris G, Dimopoulos G, Falagas ME.

Drugs. 2008;68(17):2469-81. doi: 10.2165/0003495-200868170-00005.

PMID:
19016574
19.

Effect of macrolides as part of initial empiric therapy on length of stay in patients hospitalized with community-acquired pneumonia.

Stahl JE, Barza M, DesJardin J, Martin R, Eckman MH.

Arch Intern Med. 1999 Nov 22;159(21):2576-80.

PMID:
10573047
20.

Efficacy and safety of oral and early-switch therapy for community-acquired pneumonia: a randomized controlled trial.

Castro-Guardiola A, Viejo-Rodríguez AL, Soler-Simon S, Armengou-Arxé A, Bisbe-Company V, Peñarroja-Matutano G, Bisbe-Company J, García-Bragado F.

Am J Med. 2001 Oct 1;111(5):367-74.

PMID:
11583639
Items per page

Supplemental Content

Write to the Help Desk